Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1 (original) (raw)

Abstract

Endothelin-1 (ET-1) is a 21-amino acid peptide with various biological activities including vasoconstriction and cell proliferation. To clarify the physiological and pathophysiological role of ET-1, we disrupted the mouse Edn1 locus encoding ET-1 by gene targeting and demonstrated that ET-1 is essential to the normal development of pharyngeal arch-derived tissues and organs. In this study, we focused on the phenotypic manifestations of Edn1-/- homozygous mice in the cardiovascular system. Edn1-/- homozygotes display cardiovascular malformations including interrupted aortic arch (2.3%), tubular hypoplasia of the aortic arch (4.6%), aberrant right subclavian artery (12.9%), and ventricular septal defect with abnormalities of the outflow tract (48.4%). The frequency and extent of these abnormalities are increased by treatment with neutralizing monoclonal antibodies or a selective ETA receptor antagonist BQ123. At an earlier embryonic stage, formation of pharyngeal arch arteries and endocardial cushion is disturbed in Edn1-/- homozygotes. In situ hybridization confirmed ET-1 expression in the endothelium of the arch arteries and cardiac outflow tract and the endocardial cushion as well as in the epithelium of the pharyngeal arches. Thus, ET-1 is involved in the normal development of the heart and great vessels, and circulating ET-1 and/or other ET isoforms may cause a functional redundancy, at least partly, through the ETA receptor.

293

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990 Dec 20;348(6303):730–732. doi: 10.1038/348730a0. [DOI] [PubMed] [Google Scholar]
  2. Bloch K. D., Friedrich S. P., Lee M. E., Eddy R. L., Shows T. B., Quertermous T. Structural organization and chromosomal assignment of the gene encoding endothelin. J Biol Chem. 1989 Jun 25;264(18):10851–10857. [PubMed] [Google Scholar]
  3. Bockman D. E., Redmond M. E., Waldo K., Davis H., Kirby M. L. Effect of neural crest ablation on development of the heart and arch arteries in the chick. Am J Anat. 1987 Dec;180(4):332–341. doi: 10.1002/aja.1001800403. [DOI] [PubMed] [Google Scholar]
  4. Buckingham M. Molecular biology of muscle development. Cell. 1994 Jul 15;78(1):15–21. doi: 10.1016/0092-8674(94)90568-1. [DOI] [PubMed] [Google Scholar]
  5. Chisaka O., Capecchi M. R. Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5. Nature. 1991 Apr 11;350(6318):473–479. doi: 10.1038/350473a0. [DOI] [PubMed] [Google Scholar]
  6. Fishman M. C., Stainier D. Y. Cardiovascular development. Prospects for a genetic approach. Circ Res. 1994 May;74(5):757–763. doi: 10.1161/01.res.74.5.757. [DOI] [PubMed] [Google Scholar]
  7. Fitzharris T. P., Markwald R. R. Cellular migration through the cardiac jelly matrix: a stereoanalysis by high-voltage electron microscopy. Dev Biol. 1982 Aug;92(2):315–329. doi: 10.1016/0012-1606(82)90178-6. [DOI] [PubMed] [Google Scholar]
  8. Hamaoki M., Kato H., Sugi M., Fujimoto M., Kurihara H., Yosizumi M., Yanagisawa M., Kimura S., Masaki T., Yazaki Y. Monoclonal antibodies to endothelin: application for sandwich immunoassays. Hybridoma. 1990 Feb;9(1):63–69. doi: 10.1089/hyb.1990.9.63. [DOI] [PubMed] [Google Scholar]
  9. Ihara M., Noguchi K., Saeki T., Fukuroda T., Tsuchida S., Kimura S., Fukami T., Ishikawa K., Nishikibe M., Yano M. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 1992;50(4):247–255. doi: 10.1016/0024-3205(92)90331-i. [DOI] [PubMed] [Google Scholar]
  10. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2863–2867. doi: 10.1073/pnas.86.8.2863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ito H., Hirata Y., Hiroe M., Tsujino M., Adachi S., Takamoto T., Nitta M., Taniguchi K., Marumo F. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res. 1991 Jul;69(1):209–215. doi: 10.1161/01.res.69.1.209. [DOI] [PubMed] [Google Scholar]
  12. Jacks T., Shih T. S., Schmitt E. M., Bronson R. T., Bernards A., Weinberg R. A. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet. 1994 Jul;7(3):353–361. doi: 10.1038/ng0794-353. [DOI] [PubMed] [Google Scholar]
  13. Kinsella M. G., Fitzharris T. P. Origin of cushion tissue in the developing chick heart: cinematographic recordings of in situ formation. Science. 1980 Mar 21;207(4437):1359–1360. doi: 10.1126/science.7355294. [DOI] [PubMed] [Google Scholar]
  14. Kirby M. L., Waldo K. L. Role of neural crest in congenital heart disease. Circulation. 1990 Aug;82(2):332–340. doi: 10.1161/01.cir.82.2.332. [DOI] [PubMed] [Google Scholar]
  15. Kurihara Y., Kurihara H., Suzuki H., Kodama T., Maemura K., Nagai R., Oda H., Kuwaki T., Cao W. H., Kamada N. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature. 1994 Apr 21;368(6473):703–710. doi: 10.1038/368703a0. [DOI] [PubMed] [Google Scholar]
  16. Letterio J. J., Geiser A. G., Kulkarni A. B., Roche N. S., Sporn M. B., Roberts A. B. Maternal rescue of transforming growth factor-beta 1 null mice. Science. 1994 Jun 24;264(5167):1936–1938. doi: 10.1126/science.8009224. [DOI] [PubMed] [Google Scholar]
  17. Lüscher T. F., Boulanger C. M., Dohi Y., Yang Z. H. Endothelium-derived contracting factors. Hypertension. 1992 Feb;19(2):117–130. doi: 10.1161/01.hyp.19.2.117. [DOI] [PubMed] [Google Scholar]
  18. Masaki T., Kimura S., Yanagisawa M., Goto K. Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation. 1991 Oct;84(4):1457–1468. doi: 10.1161/01.cir.84.4.1457. [DOI] [PubMed] [Google Scholar]
  19. Masaki T., Vane J. R., Vanhoutte P. M. International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol Rev. 1994 Jun;46(2):137–142. [PubMed] [Google Scholar]
  20. Matsumoto H., Suzuki N., Onda H., Fujino M. Abundance of endothelin-3 in rat intestine, pituitary gland and brain. Biochem Biophys Res Commun. 1989 Oct 16;164(1):74–80. doi: 10.1016/0006-291x(89)91684-7. [DOI] [PubMed] [Google Scholar]
  21. Miyauchi T., Yorikane R., Sakai S., Sakurai T., Okada M., Nishikibe M., Yano M., Yamaguchi I., Sugishita Y., Goto K. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res. 1993 Nov;73(5):887–897. doi: 10.1161/01.res.73.5.887. [DOI] [PubMed] [Google Scholar]
  22. Nishibatake M., Kirby M. L., Van Mierop L. H. Pathogenesis of persistent truncus arteriosus and dextroposed aorta in the chick embryo after neural crest ablation. Circulation. 1987 Jan;75(1):255–264. doi: 10.1161/01.cir.75.1.255. [DOI] [PubMed] [Google Scholar]
  23. Noden D. M. Cell movements and control of patterned tissue assembly during craniofacial development. J Craniofac Genet Dev Biol. 1991 Oct-Dec;11(4):192–213. [PubMed] [Google Scholar]
  24. Noden D. M. Origins and patterning of avian outflow tract endocardium. Development. 1991 Apr;111(4):867–876. doi: 10.1242/dev.111.4.867. [DOI] [PubMed] [Google Scholar]
  25. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990 Dec 20;348(6303):732–735. doi: 10.1038/348732a0. [DOI] [PubMed] [Google Scholar]
  26. Scambler P. J., Kelly D., Lindsay E., Williamson R., Goldberg R., Shprintzen R., Wilson D. I., Goodship J. A., Cross I. E., Burn J. Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet. 1992 May 9;339(8802):1138–1139. doi: 10.1016/0140-6736(92)90734-k. [DOI] [PubMed] [Google Scholar]
  27. Sucov H. M., Dyson E., Gumeringer C. L., Price J., Chien K. R., Evans R. M. RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev. 1994 May 1;8(9):1007–1018. doi: 10.1101/gad.8.9.1007. [DOI] [PubMed] [Google Scholar]
  28. Suzuki N., Matsumoto H., Kitada C., Masaki T., Fujino M. A sensitive sandwich-enzyme immunoassay for human endothelin. J Immunol Methods. 1989 Mar 31;118(2):245–250. doi: 10.1016/0022-1759(89)90012-4. [DOI] [PubMed] [Google Scholar]
  29. Takuwa N., Takuwa Y., Yanagisawa M., Yamashita K., Masaki T. A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem. 1989 May 15;264(14):7856–7861. [PubMed] [Google Scholar]
  30. Vainio S., Karavanova I., Jowett A., Thesleff I. Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development. Cell. 1993 Oct 8;75(1):45–58. [PubMed] [Google Scholar]
  31. Van Mierop L. H., Kutsche L. M. Cardiovascular anomalies in DiGeorge syndrome and importance of neural crest as a possible pathogenetic factor. Am J Cardiol. 1986 Jul 1;58(1):133–137. doi: 10.1016/0002-9149(86)90256-0. [DOI] [PubMed] [Google Scholar]
  32. Vanhoutte P. M. Endothelin-1. A matter of life and breath. Nature. 1994 Apr 21;368(6473):693–694. doi: 10.1038/368693a0. [DOI] [PubMed] [Google Scholar]
  33. Wilson D. I., Cross I. E., Goodship J. A., Coulthard S., Carey A. H., Scambler P. J., Bain H. H., Hunter A. S., Carter P. E., Burn J. DiGeorge syndrome with isolated aortic coarctation and isolated ventricular septal defect in three sibs with a 22q11 deletion of maternal origin. Br Heart J. 1991 Oct;66(4):308–312. doi: 10.1136/hrt.66.4.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wilson D. I., Goodship J. A., Burn J., Cross I. E., Scambler P. J. Deletions within chromosome 22q11 in familial congenital heart disease. Lancet. 1992 Sep 5;340(8819):573–575. doi: 10.1016/0140-6736(92)92107-q. [DOI] [PubMed] [Google Scholar]
  35. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  36. Yanagisawa M., Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci. 1989 Sep;10(9):374–378. doi: 10.1016/0165-6147(89)90011-4. [DOI] [PubMed] [Google Scholar]
  37. de Nucci G., Thomas R., D'Orleans-Juste P., Antunes E., Walder C., Warner T. D., Vane J. R. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9797–9800. doi: 10.1073/pnas.85.24.9797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. de la Cruz M. V., Sánchez Gómez C., Arteaga M. M., Argüello C. Experimental study of the development of the truncus and the conus in the chick embryo. J Anat. 1977 Jul;123(Pt 3):661–686. [PMC free article] [PubMed] [Google Scholar]